Stay updated on Pembrolizumab in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Colorectal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Colorectal Cancer Clinical Trial page
- Check2 days agoChange DetectedThe site footer revision changed from v3.8.0 to v3.8.1; the study record content remains unchanged.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check30 days agoChange DetectedA notice about NIH’s terminology transition appears on the page, and the ClinicalTrials.gov site revision changes from v3.7.1 to v3.7.2.SummaryDifference0.5%

- Check44 days agoChange DetectedThe footer site revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page now shows Revision: v3.7.0 in the footer, replacing the previous v3.6.6. This indicates a site update that does not alter the study data or main content.SummaryDifference0.1%

- Check79 days agoChange DetectedThe record history now includes Revision: v3.6.6, replacing Revision: v3.6.5, signaling an update to the page's version.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Colorectal Cancer Clinical Trial page.